← Back to Clinical Trials
Recruiting NCT00301119

Lung Cancer Biomarkers and Screening

Trial Parameters

Condition Lung Cancer
Sponsor NYU Langone Health
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,850
Sex ALL
Min Age 50 Years
Max Age N/A
Start Date 2000-05
Completion 2030-05

Brief Summary

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Eligibility Criteria

DISEASE CHARACTERISTICS: * Screening Cohort * At high- or low-risk for lung cancer * Smoking history ≥ 20 pack years\* * With or without workplace exposure to asbestos * NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older * Rule-Out Lung cancer group * Referred for evaluation of suspicious nodules with 1 of the following diagnoses: * Lung cancer * Nonmalignant nodules (control group) PATIENT CHARACTERISTICS: * Not pregnant * No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY: * Not specified

Related Trials